- Investing Ideas
- Bangladeshi Pharmaceuticals & Biotech Potentially Undervalued Companies
Bangladeshi Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Square Pharmaceuticals
Market Cap: ৳194.3b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳219.20
7D
-0.4%
1Y
-2.5%
Beximco Pharmaceuticals
Market Cap: ৳65.9b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳147.80
7D
1.4%
1Y
28.1%
ACME Laboratories
Market Cap: ৳17.6b
A pharmaceutical company, engages in the manufacturing, marketing, and distribution of generic pharmaceutical formulation products in Bangladesh.
ACMELAB
৳83.20
7D
0.6%
1Y
3.1%
Navana Pharmaceuticals
Market Cap: ৳7.5b
Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh.
NAVANAPHAR
৳69.40
7D
-1.1%
1Y
23.7%
Renata
Market Cap: ৳54.1b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.
RENATA
৳471.70
7D
-0.1%
1Y
-4.6%